Reciprocal Mother-Infant Voice Exposure in the Neonatal Intensive Care Unit
Hearing Each Other: Effects of Reciprocal Maternal-Infant Voice Exposure on Maternal Attachment and Breastfeeding in the NICU: A Randomized Controlled Trial
Studieoversigt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Undersøgelsestype
Undersøgelsestype
Tilmelding (Faktiske)
Tilmelding
Fase
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
-
Istanbul, Tyrkiet (Türkiye)
- Nilgün Avcı
-
-
Deltagelseskriterier
Berettigelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Beskrivelse
Inclusion Criteria:
- Mothers aged ≥18 years
- Infants ≥37 weeks gestation
- Diagnosis of transient tachypnea of the newborn (TTN)
- Infant admitted to NICU ≥6 hours
- Ability to communicate in Turkish
Exclusion Criteria:
- Infant clinical deterioration requiring transfer
- Maternal psychiatric disorder
- Hearing impairment
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Støttende pleje
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Antal våben
Våben og indgreb
Deltagergruppe / ArmDeltagergruppe / Arm |
Intervention / BehandlingIntervention / Behandling |
|---|---|
|
Eksperimentel: Reciprocal Voice Exposure Group
Reciprocal auditory stimulation consisting of maternal voice recordings played to infants and infant sound recordings played to mothers every 2 hours for 30 minutes between the 6th and 12th postpartum hours.
|
Reciprocal auditory stimulation consisting of maternal voice recordings played to infants and infant sound recordings played to mothers every 2 hours for 30 minutes between the 6th and 12th postpartum hours.
|
|
Ingen indgriben: Routine Care Group
Standard NICU care without auditory stimulation.
|
Hvad måler undersøgelsen?
Primære resultatmål
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Maternal Attachment
Tidsramme: 12th postpartum hour
|
Measured using the Maternal Attachment Inventory (26 items; scores range from 26 to 104; higher scores indicate stronger attachment).
|
12th postpartum hour
|
|
Breastfeeding Effectiveness
Tidsramme: 12th postpartum hour
|
Measured using the Bristol Breastfeeding Assessment Tool (scores range from 0 to 8; higher scores indicate more effective breastfeeding).
|
12th postpartum hour
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Breastfeeding Self-Efficacy
Tidsramme: 12th postpartum hour
|
Measured using the Breastfeeding Self-Efficacy Scale-Short Form (14 items; scores range from 14 to 70; higher scores indicate greater self-efficacy).
|
12th postpartum hour
|
|
Infant Feeding Intention
Tidsramme: 12th postpartum hour
|
Measured using the Infant Feeding Intention Scale.
Scores range from 0 to 16; higher scores indicate stronger intention to breastfeed.
|
12th postpartum hour
|
|
Perceived Insufficient Milk
Tidsramme: 12th postpartum hour
|
Measured using the Perceived Insufficient Milk Scale.
Higher scores indicate greater perceived milk insufficiency.
|
12th postpartum hour
|
|
Expressed Breast Milk Volume
Tidsramme: Between 6th and 12th postpartum hours
|
Volume of breast milk expressed using an electric pump, measured in milliliters (mL).
|
Between 6th and 12th postpartum hours
|
|
Neonatal Physiological Parameters
Tidsramme: 6th, 8th, 10th, and 12th postpartum hours
|
Respiratory Rate: Measured in breaths per minute.
|
6th, 8th, 10th, and 12th postpartum hours
|
|
Oxygen Saturation
Tidsramme: 6th, 8th, 10th, and 12th postpartum hours.
|
Peripheral oxygen saturation measured as percentage (%).
|
6th, 8th, 10th, and 12th postpartum hours.
|
|
Heart Rate
Tidsramme: 6th, 8th, 10th, and 12th postpartum hours.
|
Heart rate measured in beats per minute (bpm).
|
6th, 8th, 10th, and 12th postpartum hours.
|
|
Partial Pressure of Oxygen (pO₂)
Tidsramme: Between 6th and 12th postpartum hours.
|
Partial pressure of oxygen measured in mmHg.
|
Between 6th and 12th postpartum hours.
|
|
Partial Pressure of Carbon Dioxide (pCO₂)
Tidsramme: Between 6th and 12th postpartum hours.
|
Partial pressure of carbon dioxide measured in mmHg.
|
Between 6th and 12th postpartum hours.
|
|
Blood pH
Tidsramme: Between 6th and 12th postpartum hours.
|
Blood pH measured as a unitless value.
|
Between 6th and 12th postpartum hours.
|
|
Blood Lactate Level
Tidsramme: Between 6th and 12th postpartum hours.
|
Blood lactate level measured in mmol/L.
|
Between 6th and 12th postpartum hours.
|
Samarbejdspartnere og efterforskere
Sponsor
Sponsor
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Studiestart
Primær færdiggørelse (Faktiske)
Primær færdiggørelse
Studieafslutning (Faktiske)
Studieafslutning
Datoer for studieregistrering
Først indsendt
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Først opslået
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering sendt
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
- Luftvejssygdomme
- Lungesygdomme
- Respirationsforstyrrelser
- Spædbørn, for tidligt fødte, Sygdomme
- Spædbarn, Nyfødt, Sygdomme
- Tegn og symptomer, luftveje
- Respiratory Distress Syndrome, nyfødt
- Respiratory Distress Syndrome
- Medfødte, arvelige og neonatale sygdomme og abnormiteter
- Patologiske tilstande, tegn og symptomer
- Opførsel
- Tegn og symptomer
- Fodringsadfærd
- Takypnø
- Forbigående takypnø hos den nyfødte
- Amning
Andre undersøgelses-id-numre
Andre undersøgelses-id-numre
- Reciprocal Mother-Infant Voice
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .